-
Most Popular
Healthcare Stocks
Healthcare encompasses a wide range of organized services to prevent, treat, and diagnose medical needs and mental illnesses. The $336 billion market is expected to grow at a compound annual growth rate of 8% until 2030, demonstrating the necessity of adequate healthcare. Healthcare companies, ranging from retailer CVS to insurance giant UnitedHealth, provide these services to a massive customer base.
7 Recession-Resistant Stocks to Hold Onto for Dear Life in 2024
These seven recession-resistant stocks offer stability and potential growth even in challenging economic conditions.
7 Dependable Dividend Stocks for Long-Term Income
Explore the best dividend stocks for long-term income excelling in the healthcare, retail, tobacco and home improvement markets.
3 Pharmaceutical Stocks That Can Surge Higher Even if The Markets Correct
These are the pharmaceutical stocks to buy as they represent undervalued companies with a deep clinical pipeline that will support growth.
Other industries you might be interested in
Recent Healthcare Stocks Articles
Marijuana and Electric Car Trends Build Momentum
Volatile stock price swings characterize growth investing, but recent news confirms marijuana and next-generation battery trends.
You Can Trust Aurora Cannabis Stock Despite the Dilution
Dilutive acquisitions may hurt ACB stock in the nearer-term, but management is making the necessary moves for future success.
2 Wall Street Giants ‘All In’ for This Investment Trend
Electric Cars and Legalized Marijuana -- Major Signs of Growth Yesterday, Volkswagen and Ford announced they'll be forming a global alliance that will focus on…
New Age Beverages Is 2019’s “If” Stock
New Age Beverages hopes people turn to new types of drinks in 2019, including some infused with cannabidiol (CBD). Should you buy NBEV stock?
How Tilray Stock Has Crushed Its Short Sellers
Tilray's major shareholder has said that they won't be selling any stock anytime soon. With that being the case, TLRY stock will make more gains.
Keeping Your Portfolio Safe as Earnings Disappointments Mount
Lowered earnings forecasts make a focus on quality critical in 2019 Yesterday, Macy's stock suffered its biggest one-day drop since going public 27 years ago.…
Bristol-Myers Becomes a Cancer-Fighting Giant With Celgene Buyout
With its Celgene (CELG) buyout, Bristol-Meyers is getting a heck of a deal and will make BMY stock the top-dog cancer medicines.
3 Strikes Against Aurora Stock and Why You Can Ignore Them
Aurora stock has no shortage of immediate criticisms, but the longer-term view offers an intriguing case for speculators.
Should Warren Buffett — And You — Buy More TEVA Stock Right Now?
Teva's turnaround is working, but a serious worry is now hitting shares. Should you be buying more TEVA stock with this looming danger?
With a Potential Buyout Pending, Cronos Stock Is Only for the Bold
Recent M&A chatter surrounding tobacco giant Altria and cannabis company Cronos simultaneously adds both risk and reward to CRON stock holders.
STZ Downgrade Opens the Door for Analysts to Criticize CGC Stock
CGC stock has mostly held its ground after the pot stock craze, but pros might finally have room to point out problems with Canopy Growth.
Why Aurora Cannabis Stock Needs the U.S. to Make a Comeback
Legalization chilled ACB stock out in Canada, but anticipated legalization in the U.S. could take Aurora Cannabis stock to new highs.
Canopy Growth Stock Is Primed to Do Serious Damage
Investor sentiment has obviously gone negative for companies like Canopy Growth, but CGC stock needs just one catalyst to turn it around.
